Pharmacokinetics/Pharmacodynamics of Vaborbactam, a Novel Beta-Lactamase Inhibitor, in Combination With Meropenem

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.01659-18
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Effect of the Β-Lactamase Inhibitor Vaborbactam Combined With Meropenem Against Serine Carbapenemase-Producing Enterobacteriaceae

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2016English

Pharmacodynamics of Imipenem in Combination With Β-Lactamase Inhibitor MK7655 in a Murine Thigh Model

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2014English

Pharmacokinetics and Pharmacodynamics of a Novel Acetylcholinesterase Inhibitor, DMNG-3

Acta Neurobiologiae Experimentalis
MedicineNeuroscience
2016English

Safety, Pharmacokinetics, and Pharmacodynamics of BMS-986142, a Novel Reversible BTK Inhibitor, in Healthy Participants

European Journal of Clinical Pharmacology
MedicinePharmacology
2017English

A Novel .BETA.-lactamase Inhibitor, SF-2103 a Produced by a Streptomyces.

Journal of Antibiotics
Drug DiscoveryPharmacology
1982English

Comparative Pharmacokinetics and Pharmacodynamics of a Novel Sodium-Glucose Cotransporter 2 Inhibitor, DWP16001, With Dapagliflozin and Ipragliflozin

Pharmaceutics
Pharmaceutical Science
2020English

Pharmacokinetics and Pharmacodynamics of Verapamil in Combination With Atenolol, Metoprolol and Propranolol.

British Journal of Clinical Pharmacology
Pharmacology
1984English

Effects of Mexiletine, a CYP1A2 Inhibitor, on Tizanidine Pharmacokinetics and Pharmacodynamics

Journal of Clinical Pharmacology
Pharmacology
2010English

Dose Selection, Pharmacokinetics, and Pharmacodynamics of BRAF Inhibitor Dabrafenib (GSK2118436)

Clinical Cancer Research
Cancer ResearchOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy